(Q48169183)

English

Regimen-related toxicity of myeloablative chemotherapy with BCNU, thiotepa, and etoposide followed by autologous stem cell rescue for children with newly diagnosed glioblastoma multiforme: report from the Children's Cancer Group

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10398181

Regimen-related toxicity of myeloablative chemotherapy with BCNU, thiotepa, and etoposide followed by autologous stem cell rescue for children with newly diagnosed glioblastoma multiforme: report from the Children's Cancer Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10398181

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Grovas AC

1

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10398181

Boyett JM

2

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10398181

Lindsley K

3

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10398181

Rosenblum M

4

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10398181

Yates AJ

5

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10398181

Finlay JL

6

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10398181

publication date

1 August 1999

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10398181

Pediatric Blood & Cancer

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10398181

33

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10398181

2

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10398181

83-87

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10398181

The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199908%2933%3A2%3C83%3A%3AAID-MPO4%3E3.0.CO%3B2-G

21 January 2018

Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199908%2933%3A2%3C83%3A%3AAID-MPO4%3E3.0.CO%3B2-G

21 January 2018

Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199908%2933%3A2%3C83%3A%3AAID-MPO4%3E3.0.CO%3B2-G

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199908%2933%3A2%3C83%3A%3AAID-MPO4%3E3.0.CO%3B2-G

21 January 2018

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199908%2933%3A2%3C83%3A%3AAID-MPO4%3E3.0.CO%3B2-G

21 January 2018

Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199908%2933%3A2%3C83%3A%3AAID-MPO4%3E3.0.CO%3B2-G

21 January 2018

High dose BCNU with autologous bone marrow rescue in the treatment of recurrent malignant gliomas.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199908%2933%3A2%3C83%3A%3AAID-MPO4%3E3.0.CO%3B2-G

21 January 2018

Intracarotid BCNU leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199908%2933%3A2%3C83%3A%3AAID-MPO4%3E3.0.CO%3B2-G

21 January 2018

BCNU (1,3-bis-(2-chloroethyl)-1-nitrosurea) lung. Drug-induced pulmonary changes

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199908%2933%3A2%3C83%3A%3AAID-MPO4%3E3.0.CO%3B2-G

21 January 2018

High-dose multi-agent chemotherapy followed by bone marrow 'rescue' for malignant astrocytomas of childhood and adolescence

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199908%2933%3A2%3C83%3A%3AAID-MPO4%3E3.0.CO%3B2-G

21 January 2018

Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199908%2933%3A2%3C83%3A%3AAID-MPO4%3E3.0.CO%3B2-G

21 January 2018

High-dose chemotherapy and autologous bone marrow rescue followed by interstitial and external-beam radiotherapy in newly diagnosed pediatric malignant gliomas

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199908%2933%3A2%3C83%3A%3AAID-MPO4%3E3.0.CO%3B2-G

21 January 2018

Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199908%2933%3A2%3C83%3A%3AAID-MPO4%3E3.0.CO%3B2-G

21 January 2018

Acute lung injury following treatment with high-dose cyclophosphamide, cisplatin, and carmustine: pharmacodynamic evaluation of carmustine

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199908%2933%3A2%3C83%3A%3AAID-MPO4%3E3.0.CO%3B2-G

21 January 2018

Identifiers

10.1002/(SICI)1096-911X(199908)33:2<83::AID-MPO4>3.0.CO;2-G

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10398181

release_exzufqyzn5dnzpsnwdybycyduq

1 reference

https://api.fatcat.wiki/v0/release/exzufqyzn5dnzpsnwdybycyduq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10398181

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48169183&oldid=2188322986"